Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Inflammation is likely a key contributor to the pathogenesis of Parkinson's disease (PD), a progressively debilitating neurodegenerative disease that is accompanied by a pathological accumulation of the α-synuclein protein in a staged manner through the brain. What leads to the accumulation of α-synuclein in PD and how this relates to inflammatory pathways, however, is not entirely clear. Toll-like receptor (TLR) signaling is a major pathway mediating inflammation and, in particular, TLR2 is increasingly being implicated in PD. We have, therefore, examined the expression of TLR2 in postmortem brain tissue from PD patients and matched controls. We confirm that TLR2 is increased in PD brain, and find that levels of TLR2 correlate with the accumulation of pathological α-synuclein. TLR2 was expressed on neurons as well as microglia; however, the neuronal rather than glial expression of TLR2 was significantly increased in PD brain in accordance with disease staging, and TLR2 was strongly localized to α-synuclein positive Lewy bodies. In cell culture, activation of neuronal TLR2 induced an inflammatory response, including the secretion of inflammatory cytokines and microglial-activating chemokines, as well as the production of reactive oxygen species. Moreover, activation of neuronal TLR2 increased levels of endogenous α-synuclein protein, which was in turn associated with increased levels of the autophagy/lysosomal pathway marker p62. Finally, promoting autophagy with rapamycin or pharmacological inhibition of the TLR2 signaling pathway prevented the TLR2-mediated increase in α-synuclein in neuronal cell cultures. These results implicate neuronal TLR2 expression in human PD pathogenesis. In particular, the increased expression of TLR2 on neurons may provide new insight into disease pathogenesis and/or options for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The activation of neuronal TLR2 in the brains of patients with Parkinson's disease results in increased proinflammatory cytokine (TNF) levels and recruitment of microglia to amplify neuroinflammation as well as increased expression of asynuclein.158”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [158]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TLR2 also plays a role in neurons in response to α-synuclein in addition to microglia19,57,58.”
From Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration (2020) · cites this paper as [57]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It has been suggested that TLR2 expression is upregulated in PD postmortem human brains.291,292”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [292]
The cited source says what the claim attributes to it.
In the citing paper
“TLR2 also plays a role in neurons in response to α-synuclein in addition to microglia19,57,58.”
From Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration (2020) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“Gene expression was quantified using the comparative Ct method [24] with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the housekeeping gene.”
MethodStaging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“Pathologically, PD is defined by the selective degeneration of dopamine-producing neurons in the substantia nigra pars compacta with concomitant accumulation of α-synuclein-rich proteinaceous neuronal inclusions, termed Lewy bodies, which propagate in a predicative or staged fashion through multiple brain regions [5,…”
BackgroundSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · cited 1×
“TLRs mediate the recognition of exogenous conserved structures known as pathogen-associated molecular patterns (PAMPs) [18], and endogenous damage-associated molecular patterns (DAMPs) [33].”
BackgroundMcGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · cited 1×
“1 3 cytokines are increased in the brain, CSF and serum of PD patients [7, 17, 31] and activated microglia are prevalent in the most pathologically effected areas of the brains of patients with PD [26].”
Backgroundα-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins
Takeuchi, O., Sato, S., Horiuchi, T., Hoshino, K., Takeda, K., Dong, Z., Modlin, R. L., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.10 · Cited by 1,329 · cited 1×
“4b), which specifically activates TLR2/ TLR1 dimers [40].”
BackgroundZhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · cited 2×
“Recent reports have suggested that α-synuclein is a DAMP, capable of modulating inflammatory cytokine production in microglia [1, 3, 21, 39, 47].”
Background
Cited by
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
“TLR2 activation further enhances the aggregation of α-synuclein by regulating autophagy.(292) In line with these results, blocking the interaction between TLR2 and MyD88 can reduce the activation of glial cells, decrease α-synuclein spreading, and protect dopaminergic neurons.”
BackgroundResultAutophagy: The spotlight for cellular stress responses
Ravanan, P., Srikumar, I. F., & Talwar, P. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.08.029 · Cited by 580
Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration
Choi, I., Zhang, Y., Seegobin, S. P., Pruvost, M., Wang, Q., Purtell, K., Zhang, B., & Yue, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-15119-w · Cited by 608
Analysis of Gut Microbiota in Patients with Parkinson’s Disease
Petrov, V. A., Saltykova, I. V., Zhukova, I. A., Alifirova, V. M., Zhukova, N. G., Dorofeeva, Y. B., Tyakht, A. V., Kovarsky, B. A., Alekseev, D. G., Kostryukova, E. S., et al. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3700-7 · Cited by 487
Autophagy in neurodegenerative diseases: pathogenesis and therapy
Guo, F., Liu, X., Cai, H., & Le, W. (2018) · Brain Pathology · doi:10.1111/bpa.12545 · Cited by 444
“Notably, excess autophagosomes and autolysosomes are closely associated with p62/SQSTM1 positive inclusions, suggesting an impaired cargo digestion in lysosome (112).”
BackgroundInfluentialTargeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease
Subramaniam, S. R., & Federoff, H. J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00176 · Cited by 347
Toll-like receptors in the pathogenesis of neuroinflammation
Kumar, V. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.03.012 · Cited by 331
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Li, L., Acioglu, C., Heary, R. F., & Elkabes, S. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.10.007 · Cited by 283
“TLRs contribute to PD, and other α-synucleinopathies, by mediating the associated neuroinflammation and glial activation (Dzamko et al., 2017; Kim et al., 2018; La Vitola et al., 2018).”
BackgroundThe role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
Heidari, A., Yazdanpanah, N., & Rezaei, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02496-w · Cited by 275
Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
Li, Y., Xia, Y., Yin, S., Wan, F., Hu, J., Kou, L., Sun, Y., Wu, J., Zhou, Q., Huang, J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719807 · Cited by 230
Microglia in Parkinson's disease
Ho, M. S. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-9913-8_13 · Cited by 227
Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention
Ferreira, S. A., & Romero-Ramos, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00247 · Cited by 216
“However, the role of LRRK2 seems to be more significant due to its putative function not only in microglia, but also in other immune cells, including macrophages, dendritic cells and B cells (Dzamko, 2017).”
BackgroundParkinson disease therapy: current strategies and future research priorities
Stocchi, F., Bravi, D., Emmi, A., & Antonini, A. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01034-x · Cited by 204
“…(TLR) signalling is a major pathway that mediates inflammation, and TLR2 in particular is being increasingly implicated in PD. Neuronal expression of TLR2 is substantially increased in the brains of people with PD, and the receptor is strongly localized to α-synuclein-positive Lewy bodies 62 .”
Dutta, D., Jana, M., Majumder, M., Mondal, S., Roy, A., & Pahan, K. (2021) · Nature Communications · doi:10.1038/s41467-021-25767-1 · Cited by 195
Propagation of pathological α-synuclein in marmoset brain
Shimozawa, A., Ono, M., Takahara, D., Tarutani, A., Imura, S., Masuda-Suzukake, M., Higuchi, M., Yanai, K., Hisanaga, S.-I., & Hasegawa, M. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0413-0 · Cited by 190
Neuroinflammation and protein pathology in Parkinson’s disease dementia
Kouli, A., Camacho, M., Allinson, K., & Williams-Gray, C. H. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01083-5 · Cited by 189
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 187
“Most α-syn-positive Lewy bodies also exhibit high TLR2 immunoreactivity, indicating a strong relationship between these pathologies [162, 163].”
BackgroundImmune system responses in Parkinson's disease: Early and dynamic
Tansey, M. G., & Romero‐Ramos, M. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14290 · Cited by 178
Hughes, C. D., Choi, M. L., Ryten, M., Hopkins, L., Drews, A., Botía, J. A., Iljina, M., Rodrigues, M., Gagliano, S. A., Gandhi, S., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1907-y · Cited by 177
Anti-inflammatory Effects of Curcumin in Microglial Cells
Yu, Y., Shen, Q., Lai, Y., Park, S. Y., Ou, X., Lin, D., Jin, M., & Zhang, W. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00386 · Cited by 162
“Increased expression and activation of TLR2 is associated with the progression of neurodegenerative diseases, such as PD and dementia (Dzamko et al., 2017).”
BackgroundKim, C., Spencer, B., Rockenstein, E., Yamakado, H., Mante, M., Adame, A., Fields, J. A., Masliah, D., Iba, M., Lee, H.-J., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0276-2 · Cited by 157
Toll-like receptors and their therapeutic potential in Parkinson’s disease and α-synucleinopathies
Kouli, A., Horne, C. B., & Williams-Gray, C. H. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.042 · Cited by 143
The role of glucocerebrosidase in Parkinson disease pathogenesis
Gegg, M. E., & Schapira, A. H. V. (2018) · The FEBS Journal · doi:10.1111/febs.14393 · Cited by 123
Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2
Xia, Y., Zhang, G., Kou, L., Yin, S., Han, C., Hu, J., Wan, F., Sun, Y., Wu, J., Li, Y., et al. (2021) · Brain · doi:10.1093/brain/awab122 · Cited by 123
Gao, J., Perera, G., Bhadbhade, M., Halliday, G. M., & Dzamko, N. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008733 · Cited by 113
Self-citationInnate and adaptive immune responses in Parkinson's disease
(2020) · Progress in Brain Research · doi:10.1016/bs.pbr.2019.10.006 · Cited by 116
Lv, Q.-K., Tao, K., Wang, X.-B., Yao, X., Pang, M., Liu, J., Wang, F., & Liu, C. (2023) · Inflammation Research · doi:10.1007/s00011-022-01676-x · Cited by 127
“TLRs are directly related to inflammatory signals in microglia [218], and their activation arrests microglial autophagy.”
BackgroundContribution of astrocytes to neuropathology of neurodegenerative diseases
Acıoğlu, Ç., Li, L., & Elkabes, S. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147291 · Cited by 121
Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions
Squillace, S., & Salvemini, D. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.05.004 · Cited by 117
Understanding multifactorial architecture of Parkinson’s disease: pathophysiology to management
Kaur, R., Mehan, S., & Singh, S. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3585-x · Cited by 126
Olanow, C. W., Savolainen, M., Chu, Y., Halliday, G. M., & Kordower, J. H. (2019) · Brain · doi:10.1093/brain/awz104 · Cited by 112
Self-citationEmerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update
Gouda, N. A., Elkamhawy, A., & Cho, J. (2022) · Biomedicines · doi:10.3390/biomedicines10020371 · Cited by 120
Luppi, M. P., Azcorra, M., Caronia, G., Poulin, J.-F., Gaertner, Z. A., Gatica, S., Moreno-Ramos, O. A., Nouri, N., Dubois, M., Ma, Y. C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109975 · Cited by 116
“Several immune related pathways were also differentially enriched in GFP+ neurons, including innate immunity and Toll-like receptor (TLR) signaling (Figure S3B), which have been of recent interest in PD research (Cebrián et al., 2014; Dzamko et al., 2017).”
BackgroundLipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Hallett, P. J., Engelender, S., & Isacson, O. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1532-2 · Cited by 104
TLR2 and TLR4 in Parkinson’s disease pathogenesis: The environment takes a toll on the gut
Gorecki, A. M., Anyaegbu, C. C., & Anderton, R. S. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00271-0 · Cited by 103
“In neurons and astrocytes, TLR2 stimulation impairs α-synuclein fibril degradation [183], and treatment of SH-SY5Y and primary human neuronal cultures with the TLR2 agonist PAM3CSK4 (but not the TLR4 agonist, LPS) increases α-synuclein levels, due to impaired lysosomal degradation or autophagy [50].”
BackgroundInfluentialGabandé‐Rodríguez, E., Heras, M. M. G. D. L., & Mittelbrunn, M. (2019) · Cells · doi:10.3390/cells9010082 · Cited by 106
Hughes, C. D., Choi, M. L., Ryten, M., Hopkins, L., Drews, A., Botía, J. A., Iljina, M., Rodrigues, M., Taliun, S. A. G., Gandhi, S., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1919-7 · Cited by 100
Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations
Nguyen, L. T. N., Nguyễn, H. Đ., Kim, Y. J., Nguyen, T. T., Lai, T. T., Lee, Y. K., Ma, H., & Kim, Y. E. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223290 · Cited by 102
“In postmortem studies, TLR2 was found to be increased in the brains of patients with PD [43, 44].”
BackgroundNurr1: A vital participant in the TLR4-NF-κB signal pathway stimulated by α-synuclein in BV-2 cells
Shao, Q.-H., Yan, W.-F., Zhang, Z., Ma, K.-L., Peng, S.-Y., Cao, Y.-L., Yuan, Y.-H., & Chen, N.-H. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.04.008 · Cited by 84
“Furthermore, extracellular asynuclein from normal or dead neurons can induce neuroinflammation through excessive microglia activation, thereby exacerbating neuronal death (Bliederhaeuser et al., 2016; Dzamko et al., 2016; Hoffmann et al., 2016; Kim et al., 2013).”
LRRK2 and Rab10 coordinate macropinocytosis to mediate immunological responses in phagocytes
Liu, Z., Xu, E., Zhao, H. T., Cole, T., & West, A. B. (2020) · The EMBO Journal · doi:10.15252/embj.2020104862 · Cited by 90
“This regulation may have relevance for TLRs important in binding protein fibrils associated with neurodegenerative diseases (Dzamko et al , 2017).”
Neurovascular Inflammaging in Health and Disease
Mészáros, Á., Molnár, K., Nógrádi, B., Hernádi, Z., Nyúl-Tóth, Á., Wilhelm, I., & Krizbai, I. A. (2020) · Cells · doi:10.3390/cells9071614 · Cited by 77
“TLR2 was also detected in the post-mortem tissue of PD patients in microglia and dopaminergic neurons, and was shown to correlate with α-synuclein accumulation [106].”
BackgroundInteraction of RAGE with α-synuclein fibrils mediates inflammatory response of microglia
Long, H., Zhang, S., Zeng, S., Tong, Y., Liu, J., Liu, C., & Li, D. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111401 · Cited by 90
L'Episcopo, F., Tirolo, C., Serapide, M. F., Caniglia, S., Testa, N., Leggio, L., Vivarelli, S., Iraci, N., Pluchino, S., & Marchetti, B. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00012 · Cited by 84
“Of interest, peripheral inflammation appears greater in a percentage of subjects carrying LRRK2-G2019Smutation, with the cytokine IL1β discriminating asymptomatic LRRK2-G2019S carriers from controls (Dzamko et al., 2017).”
BackgroundCXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
Li, Y., Niu, M., Zhao, A., Kang, W., Chen, Z., Luo, N., Zhou, L., Zhu, X., Lu, L., & Liu, J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1646-6 · Cited by 85
Pandur, E., Varga, E., Tamási, K., Pap, R., Nagy, J., & Sipos, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010017 · Cited by 81
“It has been reported that TLR2 and TLR4 are expressed by neurons indicating a role of these receptors in neuronal inflammatory responses [42].”
BackgroundThe Interplay between α-Synuclein and Microglia in α-Synucleinopathies
Deyell, J., Sriparna, M., Ying, M., & Mao, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032477 · Cited by 79
“It was found that the expression of TLR1 and TLR2 after exposure to mutant A53T α-syn was significantly upregulated in primary microglia [74].”
Kim, M. S., Ra, E. A., Kweon, S. H., Seo, B. A., Ko, H. S., Oh, Y., & Lee, G. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.05.015 · Cited by 78
Koo, J., Jang, Y., Hwang, D.-J., Um, H.-S., Lee, N., Jung, J.-H., & Cho, J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.05.016 · Cited by 74
Russo, I., Kaganovich, A., Ding, J., Landeck, N., Mamais, A., Varanita, T., Biosa, A., Tessari, I., Bubacco, L., Greggio, E., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.05.012 · Cited by 77
“Discussion Prior studies have emphasized a connection between LRRK2 activity and the biology of microglia [reviewed in (Dzamko, 2017; Russo et al., 2014)].”
BackgroundWang, X., Chi, J., Huang, D., Ding, L., Zhao, X., Jiang, L., Yu, Y., & Gao, F. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8297 · Cited by 89
“Compared with the normal control group, the expression of TLR2 and TLR9 in the brain of PD patients was increased, and the expression of TLR2 was positively correlated with the accumulation of α-synuclein (36) in the body.”
BackgroundAcıoğlu, Ç., Heary, R. F., & Elkabes, S. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.02.016 · Cited by 68
Amo‐Aparicio, J., Daly, J., Højen, J. F., & Dinarello, C. A. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02830-w · Cited by 69
Caplan, I. F., & Maguire-Zeiss, K. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00417 · Cited by 63
Frederiksen, H. R., Haukedal, H., & Freude, K. (2019) · BioMed Research International · doi:10.1155/2019/7420189 · Cited by 63
“A connection between neurons, neurodegeneration, and TLRs has also been found in human brain samples of patients with Parkinson’s disease [143], where expression of the TLR 2 protein was found to be increased in patients.”
BackgroundCeramides in Parkinson’s Disease: From Recent Evidence to New Hypotheses
Plotegher, N., Bubacco, L., Greggio, E., & Civiero, L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00330 · Cited by 71
“In the CNS, TLRs are expressed in glial cells and upregulated in PD brains (Dzamko et al., 2017; Mariucci et al., 2018).”
BackgroundLiao, K., Niu, F., Hu, G., Yang, L., Dallon, B., Villarreal, D., & Buch, S. (2020) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12027 · Cited by 59
“…CNS, play a crucial role in the initiation of host immune responses following exposure to noxious stimuli, including but not limited to, HIV-1 infection (Hernández, Stevenson, Latz, & Urcuqui-Inchima, 2012), Alzheimer’s Disease (Gambuzza et al., 2014) and Parkinson’s Disease (Dzamko et al., 2017).”
Toll‐like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential
Dabi, Y. T., Ajagbe͓, A. O., & Degechisa, S. T. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.839 · Cited by 65
“TLR2 expression is increased in PD, according to an immunocytochemical analysis of postmortem human brains.(42) TLR2 was exclusively expressed in microglia in control brains, but in affected individuals, TLR2 expression was predominantly upregulated in neurons of the substantia nigra and anterior cingulate cortex.”
BackgroundLutz, P.-É., Chay, M.-A., Pacis, A., Chen, G. G., Aouabed, Z., Maffioletti, E., Théroux, J., Grenier, J., Yang, J., Aguirre, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21365-3 · Cited by 61
Liu, Z., Chan, R., Cai, Z., Liu, X., Wu, Y., Yu, Z., Feng, T., Yang, Y., & Zhang, J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02413-1 · Cited by 59
Kuo, G., Kumbhar, R., Blair, W., Dawson, V. L., Dawson, T. M., & Mao, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00797-1 · Cited by 62
Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease
Zheng, T., & Zhang, Z. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105094 · Cited by 61
Xu, W., Zheng, D., Liu, Y., Li, J., Yang, L., & Shang, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485947 · Cited by 61
Role of pattern recognition receptors of the neurovascular unit in inflamm-aging
Wilhelm, I., Nyúl-Tóth, Á., Kozma, M., Farkas, A. E., & Krizbai, I. A. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00106.2017 · Cited by 56
“TLR2 expression is significantly increased in PD brain neurons and is localized to -synuclein-positive Lewy bodies (36).”
BackgroundRegulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy
Choi, I., Heaton, G. R., Lee, Y.-K., & Yue, Z. (2022) · Science Advances · doi:10.1126/sciadv.abn1298 · Cited by 58
“4 of 9 up-regulated in dopaminergic neurons, but not in microglia, in PD patients as the disease progresses (91, 92).”
BackgroundExtracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson’s Disease
Leggio, L., Paternò, G., Vivarelli, S., Falzone, G. G., Giachino, C., Marchetti, B., & Iraci, N. (2021) · Aging and disease · doi:10.14336/ad.2021.0527 · Cited by 55
Brain clearance of protein aggregates: a close-up on astrocytes
Giusti, V., Kaur, G., Giusto, E., & Civiero, L. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00703-1 · Cited by 57
“TLRs are part of the pattern recognition receptors family, and their overexpression in both neurons and glia have been documented both in PD patients and in transgenic mice over-expressing α-Syn [108, 109].”
BackgroundNeurons and Glia Interplay in α-Synucleinopathies
Mavroeidi, P., & Xilouri, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094994 · Cited by 62
Miller, K. M., Mercado, N. M., & Sortwell, C. E. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00179-6 · Cited by 55
“2012 LB vs non-LB neurons Decreased kinesis motor proteins in neurons with LBs Increased expression of dynein in neurons with LBs Dzamko et al.(29) 2017 LB vs non-LB neurons Increased toll-like receptor 2 in neurons with LBs Schaser et al.”
Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease
Marchetti, B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101664 · Cited by 53
Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects
Eo, H., Kim, S., Jung, U. J., & Kim, S. R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237243 · Cited by 54
Quan, P., Li, X., Si, Y., Sun, L., Ding, F. F., Fan, Y., Liu, H., Wei, C., Li, R., Zhao, X. L., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01590-1 · Cited by 49
“It has been reported that pathological accumulation of α-Syn is positively correlated with increased TLR2 expression in the anterior cingulate cortex and striatum of human brains with PD [45].”
BackgroundThe interplay between α-Synuclein and NLRP3 inflammasome in Parkinson's disease
Huang, Q., Yang, P., Liu, Y., Ding, J., Lu, M., & Hu, G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115735 · Cited by 52
Microbiome-based therapies for Parkinson’s disease
Alam, M., Abbas, K., Mustafa, M., Usmani, N., & Habib, S. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1496616 · Cited by 50
LRRK2 as a target for modulating immune system responses
Russo, I., Bubacco, L., & Greggio, E. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105724 · Cited by 52
“…functions, independent investigations performed on mouse and human brain tissues failed to detect LRRK2 in microglial cells (Biskup et al., 2006; Dzamko, 2017; Dzamko et al., 2017; Higashi et al., 2007; Iannotta et al., 2020; Mandemakers et al., 2012; Sharma et al., 2011; Westerlund et al.,…”
Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
Du, T., Wang, L., Liu, W., Zhu, G., Chen, Y., & Zhang, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.645996 · Cited by 44
“TLR2 and TLR4 expressions increase in postmortem brain tissue from PD patients (Drouin-Ouellet et al., 2014; Dzamko et al., 2017), and TLR2 is strongly localized to α-Syn positive LBs (Dzamko et al., 2017).”
BackgroundInfluentialKim, C., Kwon, S., Iba, M., Spencer, B., Rockenstein, E., Mante, M., Adame, A., Shin, S. J., Fields, J. A., Rissman, R. A., et al. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00562-6 · Cited by 39
RetractedImmune-related biomarkers for Parkinson's disease
Abdi, I. Y., Ghanem, S. S., & El‐Agnaf, O. M. A. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105771 · Cited by 44
“from PD patients and in-vitro models of PD (Béraud et al., 2011; Dzamko et al., 2017).”
MethodThe Mechanism and Function of Glia in Parkinson's Disease
Zhang, X., Zhang, R., Awan, M. U. N., & Bai, J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.903469 · Cited by 44
“Moreover, microglia also acts on regulating myelination (Dzamko et al., 2017).”
BackgroundMiao, Y., & Meng, H. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01402-y · Cited by 43
“Evidence has demonstrated that TLR1 [144], TLR2 [145], TLR4 [106], and TLR5 [134], members of the TLR family, functionally interact with α-Syn, with TLR2 and TLR4 playing a more prominent role.”
BackgroundSamur, D. N., Akçay, G., Yıldırım, S., Özkan, A., Çeker, T., Derin, N., Tanrıöver, G., Aslan, M., Ağar, A., & Özbey, G. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.108977 · Cited by 40
Extracellular alpha-synuclein: Sensors, receptors, and responses
Domingues, R., Sant’Anna, R., da Fonseca, A. C. C., Robbs, B. K., Foguel, D., & Outeiro, T. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105696 · Cited by 41
Immune Signaling and Autophagy Regulation
Hua, F., Li, K., Shang, S., Wang, F., & Hu, Z. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-0602-4_26 · Cited by 39
Role of microglia autophagy and mitophagy in age-related neurodegenerative diseases
Lin, M., Yu, H., Xie, Q., Xu, Z., & Shang, P. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1100133 · Cited by 43
Balan, I. S., Boero, G., Chéry, S. L., McFarland, M. H., Lopez, A. G., & Morrow, A. L. (2024) · Life · doi:10.3390/life14050582 · Cited by 44
Vinpocetine regulates levels of circulating TLRs in Parkinson’s disease patients
Ping, Z., Wu, X., Xufang, X., & Shao, L. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3592-y · Cited by 39
TLR7/8 in the Pathogenesis of Parkinson’s Disease
Campolo, M., Filippone, A., Biondo, C., Mancuso, G., Casili, G., Lanza, M., Cuzzocrea, S., Esposito, E., & Paterniti, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249384 · Cited by 38
“In particular, recent papers have focused the attention only on the roles of extracellular TLR, such as 2 and 4, in the pathogenesis of PD [20,21], never looking to the involvement of the other TLRs, such as the intracellular TLR7, 8, and 9 in PD etiology.”
BackgroundRepurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
Jung, Y. J., Tweedie, D., Scerba, M. T., Kim, D. S., Palmas, M. F., Pisanu, A., Carta, A. R., & Greig, N. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.656921 · Cited by 38
Szabo, M. P., Iba, M., Nath, A., Masliah, E., & Kim, C. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00755-7 · Cited by 37
Graves, N. J., Gambin, Y., & Sierecki, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512134 · Cited by 38
Papendorf, J. J., Krüger, E., & Ebstein, F. (2022) · Cells · doi:10.3390/cells11091422 · Cited by 39
Targeting Microglial and Neuronal Toll-like Receptor 2 in Synucleinopathies
Kwon, S., Iba, M., Masliah, E., & Kim, C. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.5.547 · Cited by 35
“These findings were supported by Dzamko et al, who described the induction of neuronal TLR2 in PD patient brains [50].”
Resultde Almeida, E. J. R., Ibrahim, H. J., Schetinger, M. R. C., de Andrade, C. M., & Cardoso, A. M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03713-x · Cited by 36
Conte, C., Ingrassia, A. M. T., Brevé, J. J. P., Bol, J. G. J. M., Huisman, E., van Dam, A., Beccari, T., & van de Berg, W. D. J. (2023) · Cells · doi:10.3390/cells12101368 · Cited by 36
“It is well known that the activation of the toll-like receptor (TLR) signaling pathway plays a key role in neuroinflammation and subsequent neurodegeneration [12,13].”
BackgroundParkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
Gundersen, V. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.580311 · Cited by 33
Aurelian, L., & Balan, I. S. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05220-4 · Cited by 37
Cheng, Y., Tong, Q., Yuan, Y., Song, X., Jiang, W., Wang, Y., Li, W., Li, Y., & Zhang, K. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02720-1 · Cited by 33
Anti-neuroinflammatory effect of curcumin on Pam3CSK4-stimulated microglial cells
Jin, M., Park, S. Y., Shen, Q., Lai, Y., Ou, X., Mao, Z., Lin, D., Yu, Y., & Zhang, W. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3217 · Cited by 37
“A previous study using TLR2 knock-out mice revealed that the expression of the TLR2 receptor is required for the development and persistence of α -synuclein accumulation, α -synuclein-mediated neurodegeneration and experimental spontaneous pain due to peripheral nerve injury (26).”
InfluentialSerapide, M. F., L’Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Giachino, C., & Marchetti, B. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00024 · Cited by 33
“…and autophagy contribute to DAergic neuron demise in PD (Marchetti and Abbracchio, 2005; Frank-Cannon et al., 2008; Gao et al., 2011; Lastres-Becker et al., 2012; Cannon and Greenamyre, 2013; Hirsch et al., 2013; Dzamko et al., 2015, 2017; Langston, 2017; Blauwendraat et al., 2019).”
Background
Metadata
- Authors
- Dzamko, N., Gysbers, A., Perera, G., Bahar, A., Shankar, A., Gao, J., Fu, Y., & Halliday, G. M.
- Affiliations
- UNSW Sydney (AU)
- Neuroscience Research Australia (AU)
- Corresponding author
- Dzamko, Nicolas
- Halliday, Glenda M.
- Venue
- Acta Neuropathologica
- Published
- 2016-11-25
- Volume
- 133
- Issue
- 2
- Pages
- 303-319
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC5250664
- OpenAlex
- W2554874133
- Semantic Scholar
- 6d5ed92f5026eb13731b365c8793acdf5588d2a7
- Cited by
- 273
- References
- 49
- Citations by year
- 2026: 11 · 2025: 24 · 2024: 34 · 2023: 35 · 2022: 42 · 2021: 40 · 2020: 26 · 2019: 23 · 2018: 24 · 2017: 12
- FWCI
- 14.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Health and Medical Research Council
- Parkinson's NSW
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, TLR2, alpha-synuclein, neuroinflammation, Lewy bodies, microglia, autophagy, p62, reactive oxygen species, inflammatory cytokines, chemokines, disease staging, rapamycin, TLR2 signaling
- MeSH terms
- Aged, Aged, 80 and over, Brain, Female, Humans, Inflammation, Male, Middle Aged, Parkinson Disease, Toll-Like Receptor 2, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.